sulfinpyrazone
Sign in to saveAlso known as ANR315, Anturane®, Apo-sulfinpyrazone®, G 28315, NSC 75925, suphinpyrazone, Sulfoxyphenylpyrazolidine, 4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione
Sulfinpyrazone is a uricosuric medication used to treat gout. It also sometimes is used to reduce platelet aggregation by inhibiting degranulation of platelets which reduces the release of ADP and thromboxane.
Research
1,309 papers- Sulfinpyrazone: a review of its pharmacological properties and therapeutic use.Drugs · 1980
- Sulfinpyrazone: relationship between dose, kinetics, plasma concentrations and biological effects.Thrombosis research. Supplement · 1983
- Sulfinpyrazone alone?Circulation · 1981
- Sulfinpyrazone after myocardial infarction.The Medical journal of Australia · 1980
- Sulfinpyrazone after myocardial infarction?The Medical journal of Australia · 1978
via PubMed
~1 min read
Encyclopedic overview
3 sectionsContents
- Contraindications
- Research
- References
Sulfinpyrazone is a uricosuric medication used to treat gout. It also sometimes is used to reduce platelet aggregation by inhibiting degranulation of platelets which reduces the release of ADP and thromboxane.
Like other uricosurics, sulfinpyrazone works by competitively inhibiting uric acid reabsorption in the proximal tubule of the kidney.
Excerpted from Wikipedia’s “sulfinpyrazone” article, available under the CC BY-SA 4.0 licence.
Available in 14 languages
- Español
- Deutsch
- 日本語
- Русский
- Italiano
- العربية
- Bahasa Indonesia
- Finnish
- Serbian
- Serbian (Latin)
- Tiếng Việt
- Welsh
- فارسی
via Wikidata sitelinks · CC0